The introduction of HIV during 1979-80 in a sexually active homosexual population of Stockholm. NLM AIDSLINE Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The introduction of HIV during 1979-80 in a sexually active homosexual population of Stockholm.

Scand J Infect Dis. 1987;19(3):285-8. Unique Identifier : AIDSLINE MED/87291889
Von Krogh G; Brostrom C; Hermanson J; Von Sydow M; Biberfeld G; Sandstrom E; Bottiger M

Abstract: Serological tests for hepatitis A (HA) and B (HB), syphilis and HIV were performed on blood samples from 3 groups of homosexual men: 220 and 124 asymptomatic men being investigated in 1978 and 1980 respectively and another 98 men suffering from HA during the winter 1979-80. The two asymptomatic groups revealed similar test results with respect to HA, HB and syphilis: about 25% had markers for HA, 50% for HB and 10-16% for syphilis. The 1979-80 HA group had a comparatively high frequency of markers for HB (64%) and for syphilis (34%), indicating that these men were sexually highly active. While all of the men in the 1978 test group were free from HIV antibodies, 2% of the 1980 and 6% of the 1979-80 group had antibodies to the virus. The results indicate that HIV was introduced to the gay population of Stockholm during 1979-80.
Keywords: Acquired Immunodeficiency Syndrome/DIAGNOSIS/*TRANSMISSION Antibodies, Viral/ANALYSIS Hepatitis B/TRANSMISSION Hepatitis B Antigens/ANALYSIS *Homosexuality Human HIV/IMMUNOLOGY Male Sex Behavior Sweden JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/diagnosis/KWDtransmissionantibodies,viral/analysishepatitisb/transmissionhepatitisbantigens/analysisKWDhomosexualityhumanhiv/immunologymalesexbehaviorswedenjournalarticle
871130
M87B0214

Copyright © 1987 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1987. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1987. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .